News
15h
GlobalData on MSNHansa’s Idefirix shows potential as pre-treatment to ElevidysHansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with ...
SRPT's Q2 report, set to arrive Aug. 6, is likely to have Elevidys updates, restructuring plans and sales outlook in sharp investor focus.
Swedish biotech Hansa Biopharma on Friday released encouraging top-line results from three patients with Duchenne muscular ...
After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...
President Trump's executive order to "identify and take appropriate action to correct past misconduct by the Federal Government related to censorship of protected speech" is good enough, DOJ tells ...
6h
Stockhead on MSNHealth Check: Audeara strives to be ‘the next Cochlear’ in affordable hearing collabHearing minnow Audeara has entered an alliance with Ear Science Institute Australia to develop an affordable bone conduction hearing device.
6h
Raw Story on MSN'A plant!' Far-right turns on MAGA mega influencer after major ousterA far-right influencer close to President Donald Trump faces suspicion from some of her fellow conspiracy theorists, who ...
The cost of high-end, breakthrough medications traumatizes patients and their families. According to USAfacts, “national ...
The FDA's top vaccine official is stepping down after just 3 months in a role that upset drug companies, patient groups and some political leaders.
Through our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or Agency) that may affect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results